LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

Zoetis Inc

Geschlossen

BrancheGesundheitswesen

120.78 -0.18

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

120

Max

121.87

Schlüsselkennzahlen

By Trading Economics

Einkommen

3M

721M

Verkäufe

-60M

2.4B

KGV

Branchendurchschnitt

20.167

105.69

EPS

1.7

Dividendenrendite

1.61

Gewinnspanne

30.042

Angestellte

13,800

EBITDA

-14M

1.1B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+38.97% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.61%

2.37%

Nächste Dividendenausschüttung

2. Dez. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-11B

53B

Vorheriger Eröffnungskurs

120.96

Vorheriger Schlusskurs

120.78

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Zoetis Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Aug. 2025, 11:06 UTC

Ergebnisse

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5. Aug. 2025, 11:06 UTC

Ergebnisse

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5. Aug. 2025, 11:05 UTC

Ergebnisse

Zoetis 2Q Adj EPS $1.76 >ZTS

6. Mai 2025, 11:14 UTC

Ergebnisse

Zoetis Sees FY25 Adj EPS $6.20-Adj EPS $6.30 >ZTS

6. Mai 2025, 11:14 UTC

Ergebnisse

Zoetis Sees FY25 Rev $9.43B-$9.58B >ZTS

6. Mai 2025, 11:13 UTC

Ergebnisse

Zoetis 1Q Adj EPS $1.48 >ZTS

6. Mai 2025, 11:00 UTC

Ergebnisse

Zoetis 1Q Net $631M >ZTS

6. Mai 2025, 11:00 UTC

Ergebnisse

Zoetis 1Q Rev $2.22B >ZTS

6. Mai 2025, 11:00 UTC

Ergebnisse

Zoetis 1Q EPS $1.41 >ZTS

20. Feb. 2025, 08:00 UTC

Top News

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13. Feb. 2025, 13:47 UTC

Ergebnisse

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13. Feb. 2025, 12:09 UTC

Ergebnisse

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13. Feb. 2025, 12:08 UTC

Ergebnisse

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13. Feb. 2025, 12:08 UTC

Ergebnisse

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13. Feb. 2025, 12:00 UTC

Ergebnisse

Zoetis 4Q EPS $1.29 >ZTS

13. Feb. 2025, 12:00 UTC

Ergebnisse

Zoetis 4Q Rev $2.32B >ZTS

13. Feb. 2025, 12:00 UTC

Ergebnisse

Zoetis 4Q Net $581M >ZTS

Peer-Vergleich

Kursveränderung

Zoetis Inc Prognose

Kursziel

By TipRanks

38.97% Vorteil

12-Monats-Prognose

Durchschnitt 168.5 USD  38.97%

Hoch 200 USD

Tief 140 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Zoetis Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

7

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

152.58 / N/AUnterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat